Comment on: "A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance"

Appl Health Econ Health Policy. 2020 Jun;18(3):457-458. doi: 10.1007/s40258-020-00574-9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents*
  • Drug Resistance, Bacterial / drug effects*
  • Humans
  • Patient Preference

Substances

  • Anti-Bacterial Agents